| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |